APGE
Apogee Therapeutics

415
Mkt Cap
$4.59B
Volume
2.85M
52W High
$84.56
52W Low
$26.20
PE Ratio
-15.67
APGE Fundamentals
Price
$66.04
Prev Close
$68.50
Open
$68.06
50D MA
$71.39
Beta
0.00
Avg. Volume
830,659.22
EPS (Annual)
-$4.22
P/B
5.00
Rev/Employee
$0.00
$3,859.60
Loading...
Loading...
News
all
press releases
JPMorgan Chase & Co. Buys 417,161 Shares of Apogee Therapeutics Inc. $APGE
JPMorgan Chase & Co. increased its stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 57.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,137,731 shares of the company's stock after acquiring an additional 417,161...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
BTIG Research Reiterates "Buy" Rating for Apogee Therapeutics (NASDAQ:APGE)
BTIG Research restated a "buy" rating and set a $137.00 target price on shares of Apogee Therapeutics in a report on Monday...
MarketBeat·6d ago
News Placeholder
HighVista Strategies LLC Grows Position in Apogee Therapeutics Inc. $APGE
HighVista Strategies LLC increased its position in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 137.7% during the 3rd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·6d ago
News Placeholder
Boxer Capital Management LLC Acquires New Holdings in Apogee Therapeutics Inc. $APGE
Boxer Capital Management LLC acquired a new stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) in the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·7d ago
News Placeholder
Braidwell LP Sells 39,767 Shares of Apogee Therapeutics Inc. $APGE
Braidwell LP lessened its holdings in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 2.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·7d ago
News Placeholder
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) CEO Sells 20,000 Shares of Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of Apogee Therapeutics stock in a transaction on Wednesday, March 11th. The shares were sold...
MarketBeat·8d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) CEO Michael Thomas Henderson Sells 20,000 Shares
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 11th. The stock was...
MarketBeat·8d ago
News Placeholder
Barclays PLC Buys 33,494 Shares of Apogee Therapeutics Inc. $APGE
Barclays PLC boosted its stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 5.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·10d ago
News Placeholder
Jefferies Financial Group Inc. Sells 74,273 Shares of Apogee Therapeutics Inc. $APGE
Jefferies Financial Group Inc. trimmed its position in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 11.6% during the third quarter, according to its most recent disclosure with...
MarketBeat·13d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Insider Sells $390,830.00 in Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 5,500 shares of Apogee Therapeutics stock in a transaction dated Wednesday, March 4th. The shares were sold at an...
MarketBeat·15d ago
<
1
2
...
>

Latest APGE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.